… significantly below our fair value estimate. We encourage investors to consider a wide margin of safety around this high - risk stock, and suggest investors avoid taking a position at the present time.
… John Kurtzweil quit for a smaller technology firm. The LED lighting company's financial statements have reflected the high risk of surprises since June 2010. Kurtzweil resigned yesterday as CFO, but he plans to continue as a Cree employee until …
… risks are obvious, but insiders appear to believe the risks are worth it for the considerable upside potential in their high - risk , high-return biotech. Celsion has developed ThermoDox treatment therapy, which uses heat-sensitive nano-particles …
… exploration start-up, continuing private equity's dive into the Gulf of Mexico but differing from many in its focus on the high - risk , high-reward deepwater business. "With the improved safety procedures and ramp-up in activity, the timing is …
… Estate Bull 3x Shares DRN should be viewed as a specialty satellite holding best suited for the sophisticated carrying high - risk tolerance and an understanding of the fund's mechanics. This exchange-traded fund is designed to deliver 3 times …
… would like to stick with no load and low fee funds such as Vanguard, Fidelity, Schwab, TRow, Invesco... I have very high risk tolerance and I am willing to invest into 90%-100% equity portfolio knowing that I have 30 years before pulling the …
… 10% after hours. In my market update video I said on a push to $30 I think the $28 and $27 puts would be worth a high risk trade. Sure enough JCP pushed up at the open and breached $30. At that point the puts were a prime risk trade opportunity …
… When volatility was low, indicated by the red circles, equity prices approached secular highs. This was actually a high - risk time to buy, as prices fell sharply, shortly thereafter. Source: James Montier, GMO[4] For CPT, the return …
… development, of the offshore block. While CNQ has a history of being a sole owner for much of its asset base, we find the high - risk nature of offshore exploration and development to be conducive to joint ventures and consider this a positive for CNQ …
(Reuters) - Adding Johnson & Johnson's advanced prostate cancer drug, Zytiga, to hormone therapy before surgery has been shown for the first time to eradicate tumors in some men with high - risk forms...